Scientists have moved closer to developing a universal flu vaccine by using the 2009 pandemic to study why some people seem to resist severe illness.
Researchers at Imperial College London asked volunteers to donate blood samples just as the swine flu pandemic was getting underway and report any symptoms they experienced over the next two flu seasons.
They found that those who avoided severe illness had more CD8 T cells, a type of virus-killing immune cell, in their blood at the start of the pandemic.
They believe a vaccine that stimulates the body to produce more of these cells could be effective at preventing flu viruses, including new strains that cross into humans from birds and pigs, from causing serious disease.
The findings are published in Nature Medicine.
Professor Ajit Lalvani from the National Heart and Lung Institute at Imperial College London, who led the study, said: “New strains of flu are continuously emerging, some of which are deadly, and so the Holy Grail is to create a universal vaccine that would be effective against all strains of flu.”
Today’s flu vaccines make the immune system produce antibodies that recognise structures on the surface of the virus to prevent infection with the most prevalent circulating strains. But they are usually one step behind as they have to be changed each year as new viruses with different surface structures evolve.
Previously, experimental models had suggested that T cells may protect against flu symptoms but until now this idea has not been tested in humans during a pandemic.
Professor Lalvani’s team rapidly recruited 342 staff and students at Imperial to take part in their study in autumn 2009. The volunteers donated blood samples and were given nasal swabs. They were sent emails every three weeks asking them to fill in a survey about their health. If they experienced flu symptoms, they took a nasal swab and sent it back to the lab.
They found that those who fell more severely ill with flu had fewer CD8 T cells in their blood, and those who caught flu but had no symptoms or only mild symptoms had more of these cells.
Professor Lalvani said, “The immune system produces these CD8 T cells in response to usual seasonal flu. Unlike antibodies, they target the core of the virus, which doesn’t change, even in new pandemic strains. The 2009 pandemic provided a unique natural experiment to test whether T cells could recognise, and protect us against, new strains that we haven’t encountered before and to which we lack antibodies.
“Our findings suggest that by making the body produce more of this specific type of CD8 T cell, you can protect people against symptomatic illness. This provides the blueprint for developing a universal flu vaccine.
The Latest Bing News on:
Universal flu vaccine
- Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024on April 27, 2024 at 1:00 am
LHNVD-105, a universal influenza vaccine, shows strong immunogenicity at low doses in pigs, validating previous studies in rodents Monoclonal antibodies generated by LHNVD-105 demonstrates the need ...
- Bhutan closer to achieving universal immunisation coverage with 99.6 % children vaccinatedon April 26, 2024 at 7:08 am
Bhutan has made significant progress in achieving the Universal Immunisation coverage target. The country has vaccinated 99.6 per cent of children so far. This is according to data released by the ...
- As bird flu outbreaks worsen, experts say the situation threatens to spiral out of controlon April 26, 2024 at 2:30 am
Recent testing has revealed H5N1 outbreaks are more widespread then previously thought yet we aren't testing enough ...
- UC Riverside researchers develop potential universal vaccine strategyon April 25, 2024 at 3:26 pm
Despite ongoing challenges in achieving full protection against evolving viruses with traditional vaccines, researchers at the University of California, Riverside, developed a “promising” new vaccine ...
- Cidara regains rights to flu med after Janssen makes good on promise to diveston April 24, 2024 at 1:05 pm
Cidara Therapeutics already knew that Janssen planned to hand off its obligations to their flu prophylaxis candidate to another entity. Now it turns out that entity will be …Cidara. | Cidara ...
- Is There a Vaccine for H5N1 Influenza?on April 22, 2024 at 2:31 pm
On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...
- A Universal Vaccine Against Any Viral Variant? A New Study Suggests It’s Possibleon April 22, 2024 at 1:37 pm
A universal vaccine would train the body to recognize and eradicate new viral strains, even if they've mutated into nearly unrecognizable forms.
- No More Endless Boosters? Scientists Develop One-for-All Virus Vaccineon April 22, 2024 at 12:32 am
End of the line for endless boosters? Researchers at UC Riverside have developed a new vaccine approach using RNA that is effective against any strain of a virus and can be used safely even by babies ...
- Universal vaccine may be effective against any variant of any viruson April 16, 2024 at 4:54 pm
Scientists at the University of California, Riverside (UCR) has recently developed a revolutionary RNA-based strategy for a universal vaccine ...
- Genetics-based universal vaccine could be effective against any viral strainon April 16, 2024 at 7:32 am
Genetics-based "one-and-done" vaccines for the flu and COVID-19 could prove more effective and easier to craft than current jabs, researchers report.
The Latest Google Headlines on:
Universal flu vaccine
[google_news title=”” keyword=”Universal flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Flu vaccine
- Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024on April 27, 2024 at 1:00 am
LHNVD-105, a universal influenza vaccine, shows strong immunogenicity at low doses in pigs, validating previous studies in rodents Monoclonal antibodies generated by LHNVD-105 demonstrates the need for targeting multiple different conserved regions on the ...
- Flu shot fatigue: influenza vaccination rates in R.I. continue to fall post-pandemicon April 25, 2024 at 2:30 am
Chalk it up to shot sickness, or maybe just an inflated sense of immunity. Either way, fewer Rhode Island adults rolled up their sleeves for a flu shot this year, though the state remains a national leader in its influenza vaccination rate,
The Latest Google Headlines on:
Flu vaccine
[google_news title=”” keyword=”flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]